Ulrike Philippar, PhD

Senior Director Oncology, Global Head of Discovery Hematological Malignancies at Johnson & Johnson Innovative Medicine

Speaker

Ulrike Philippar, Ph.D. is Vice President Oncology, Global Head of Discovery, Johnson & Johnson Innovative Medicine. In this role, she is responsible for leading J&J’s drug discovery programs across hematological and solid cancer indications as well as Immuno-Oncology from target identification to Ph1 start. Dr. Philippar’s group is working across modalities, including small molecules, biologics and cell therapies.

Dr. Philippar first joined J&J in January 2013.

Prior to her current role, Dr. Philippar was a program and team leader at Merck Oncology, Drug Discovery, Boston, MA, USA, in a number of roles of increasing responsibility.

Dr. Philippar is a scientist by training, she obtained a Masters and a Ph.D. in Cellular Biology from the University of Tübingen, Germany, and completed a postdoctoral fellowship at the Center for Cancer Research, MIT, Cambridge, USA.

Dr. Philippar authored more than thirty publications, and holds several memberships, including at the American Association for Cancer Research (AACR) and American Society of Hematology (ASH).